Advertisement
Home 2015

Archives

Anthrasil

FDA Approves New Treatment for Anthrax

0
FDA cites preparedness for intentional release of anthrax
U.S. Food and Drug Administration approval of Eylea (aflibercept) has been expanded to treat diabetic retinopathy among people with diabetic macular edema

FDA: Eylea Approval Expanded to Include Diabetic Retinopathy

0
Among people with diabetic macular edema
Symptomatic bradycardia can occur when amiodarone is taken with new hepatitis C medications

FDA Warns Against Amiodarone Use With Hepatitis C Meds

0
Adding ledipasvir/sofosbuvir or sofosbuvir to amiodarone could cause symptomatic bradycardia
Doctors are not telling a majority of their patients diagnosed with Alzheimer's that they have the degenerative brain disease

Doctors May Not Be Informing of Alzheimer’s Diagnosis

0
Only 45 percent of people with Alzheimer's or their caregivers say they were told of the diagnosis
The Society of Pediatric Cardiology Training Program Directors have developed the 2015 Training Guidelines for Pediatric Cardiology Fellowship Program together with the American College of Cardiology

Revised Guidelines Released for Peds Cardiology Fellowship

0
Societies release revised training guidelines, updating 2005 guidelines
The newest iteration of the Core Cardiovascular Training Statement

ACC Releases Latest Training Recs for Cardiology Fellows

0
COCATS 4 updates training recommendations and includes communication, practice-based learning
More than 300 students and staff at Olathe Northwest High School were tested last week after a reported case of tuberculosis at the school. The testing identified 27 more people with tuberculosis infection

Over Two Dozen Test Positive for TB at Kansas High School

0
Officials testing all who might have been in close contact with the first confirmed case of TB
As health officials in Kansas struggle with an outbreak of tuberculosis at a local high school

CDC: Decline in TB Rates in the United States Slowing Down

0
2013 decrease is smallest seen in more than a decade
Cholbam (cholic acid) capsules have been approved by the U.S. Food and Drug Administration to treat adults and children with bile acid synthesis disorders and peroxisomal disorders

FDA Approves Cholbam for Rare Bile Acid Synthesis Disorders

0
Drug is approved as an oral treatment for children aged 3 weeks and older, and adults
The Obama Administration reported Monday the largest drop in the number of Americans without health insurance since the Johnson administration expanded health coverage through Medicare and Medicaid 50 years ago.

More Than 16 Million Americans Have Gained Coverage Under ACA

0
White House announces historic drop in number of uninsured Americans